“A clinical impact study of dermatologists’ use of the 23- or 35-gene expression profile tests to guide surgical excision and enhance management plan confidence”, J of Skin, vol. 6, no. 6, p. s99, Nov. 2022, doi: 10.25251/skin.6.supp.99.